Breaking News

     >>>>>>> Police arrests 3 drug dealers including member of Sabal Leikai Ward Number-3 in possession various contraband drugs at Kheragao Sabal Leikai >>>>>     >>> Members of United Forum of BSNL Employees Unions And Association Manipur carried out protest demonstration condemning the murder of Gurumayum Surajkumar by his uncle >>>>>     >>>>>>>>>New Impact Bouquet available from September 2020 >>>>>     >>>>>>>>> India's COVID-19 tally crosses 91.39 Lakhs with over 44 Thousand new cases reported in last 24 hours; recovery rate above 93 per cent >>>>>     >>>>>> Department of Foreign Language, Manipur University has introduced B.A. Honours on Korean Language >>>>>     >>>>>> State Nodal Officer of National Viral Hepatitis Control Programme Dr. RK Rosie appealed to get themselves tested for Hepatitis under National Viral Hepatitis Control Programme to eliminate Hepatitis from India by 2030 >>>>>     >>>>> Rajya Sabha MP and Titular King of Manipur Leishemba Sanajaoba has appealed to experts to discourse on Anglo-Manipuri War to start necessary measures to preserve the history >>>>>>

Items filtered by date: Sunday, 18 October 2020

Imphal, 18 October 2020 ( Evening News ) : Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, Gavi and the Bill & Melinda Gates Foundation will accelerate the manufacture and delivery of up to 200 million to 300 million doses of safe and effective COVID-19 vaccines for India and low-and middle-income countries by December. Executive Director of Serum Institute of India, Dr.Suresh Jadhav said that India may get COVID-19 vaccine by March 2021 with approval from the Drug Control General of India (DCGI) and provided the regulators signal with the processes fast as multiple manufacturers are working on it. It may be mentioned that SIL CEO Adar Poonawala Serum had earlier said that SIL can produce 700 to 800 million vaccine dosages every year once things are streamlined. Pune-based pharmaceutical company, SIL signed a deal with Malinda Gates Foundation and Gavi Vaccine Alliance to make over 200 million COVID 19 vaccine doses available for poorer countries, including India, to be priced at a maximum of 3 dollars each, which is 220.33 Indian Rupees. It may be mentioned that the phase- three or the last stage of clinical trial of the Covid-19 vaccine 'COVI-SHIELD', being developed by Oxford University, and manufactured by the Serum Institute of India (SII) is currently underway.

Published in Breaking news
« October 2020 »
Mon Tue Wed Thu Fri Sat Sun
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

Media Partners